Show simple item record

dc.contributor.authorFisker, Ane B
dc.contributor.authorNebie, Eric
dc.contributor.authorSchoeps, Anja
dc.contributor.authorMartins, Cesario
dc.contributor.authorRodrigues, Amabelia
dc.contributor.authorZakane, Alphonse
dc.contributor.authorKagone, Moubassira
dc.contributor.authorByberg, Stine
dc.contributor.authorThysen, Sanne M
dc.contributor.authorTiendrebeogo, Justin
dc.contributor.authorCoulibaly, Boubacar
dc.contributor.authorSankoh, Osman
dc.contributor.authorBecher, Heiko
dc.contributor.authorWhittle, Hilton C
dc.contributor.authorvan der Klis, Fiona R M
dc.contributor.authorBenn, Christine S
dc.contributor.authorSie, Ali
dc.contributor.authorMüller, Olaf
dc.contributor.authorAaby, Peter
dc.date.accessioned2018-03-08T11:40:02Z
dc.date.available2018-03-08T11:40:02Z
dc.date.issued2017-11-21
dc.identifier.citationA two-centre randomised trial of an additional early dose of measles vaccine: Effects on mortality and measles antibody levels. 2017 Clin. Infect. Dis.en
dc.identifier.issn1537-6591
dc.identifier.pmid29177407
dc.identifier.doi10.1093/cid/cix1033
dc.identifier.urihttp://hdl.handle.net/10029/621557
dc.description.abstractBesides protecting against measles, measles vaccine (MV) may have beneficial non-specific effects. We tested the effect of an additional early MV on mortality and measles antibody levels.
dc.language.isoenen
dc.rightsinfo:eu-repo/semantics/closedAccessen
dc.titleA two-centre randomised trial of an additional early dose of measles vaccine: Effects on mortality and measles antibody levels.en
dc.typeArticleen
dc.identifier.journalClin Infect Dis 2018; 66(10):1573-80en
html.description.abstractBesides protecting against measles, measles vaccine (MV) may have beneficial non-specific effects. We tested the effect of an additional early MV on mortality and measles antibody levels.


This item appears in the following Collection(s)

Show simple item record